Epilepsy Research
Volume 26, Issue 1 , Pages 267-279 , December 1996

Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures

  • A. Vezzani

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39 (2) 3901 4410; fax: +39 (2) 354 6277.
    • Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy
    • ,
  • C. Schwarzer

      Affiliations

    • Department of Pharmacology, University of Innsbruck, Innsbruck, Austria
    • ,
  • E.W. Lothman

      Affiliations

    • Department of Neurology, University of Virginia, Charlottesville, VA, USA
    • This work is dedicated to Dr. Eric W. Lothman, a dear friend and an outstanding scientist who passed away on April 15 1995.
    • ,
  • J. Williamson

      Affiliations

    • Department of Neurology, University of Virginia, Charlottesville, VA, USA
    • ,
  • G. Sperk

      Affiliations

    • Department of Pharmacology, University of Innsbruck, Innsbruck, Austria

Received 28 September 1995 ,Accepted 4 March 1996.

References 

  1. Bakst I, Avendano C, Morrison JH, Amaral DG. An experimental analysis of the origins of somatostatin-like immunoreactivity in the dentate gyrus of the rat. J. Neurosci. 1986;6:1452–1462
  2. Betlmann R, Widmann R, Olenik C, Meyer DK, Maas D, Marksteiner J, et al. Enhanced rate of expression and biosynthesis of neuropeptide Y after kainic acid induced seizures. J. Neurochem. 1991;56:525–530
  3. Ben-Ari Y. Limbic seizures and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience. 1985;14:375–403
  4. Bendotti C, Vezzani A, Tarizzo G, Samanin R. Increased expression of GAP-43, somatostatin and neuropeptide Y mRNA in the hippocampus during development of hippocampal kindling in rats. Eur. J. Neurosci. 1993;5:1312–1320
  5. Brooks PA, Kelly JS, Allen JM, Smith DAS, Stone TW. Direct excitatory effects of neuropeptide Y (NPY) on rat hippocampal neurons in vitro. Brain Res. 1987;408:295–298
  6. Cavazos JE, Golarai G, Sutula TP. Mossy fibre synaptic reorganization induced by kindling: Time course of development, progression, and permanence. J. Neurosci. 1991;11:2795–2803
  7. Colmers WF, Klapstein GJ, Fournier A, St-Pierre S, Treherne KA. Presynaptic inhibition by neuropeptide Y in rat hippocampal slice in vitro is mediated by a Y2 receptor. Br. J. Pharmacol. 1991;102:41–44
  8. DeLanerolle NC, Kim JH, Robbins RJ, Spencer DD. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 1989;495:387–395
  9. Deller T, Leranth C. Synaptic connections of neuropeptide Y (NPY) immunoreactive neurons in the hilar area of the rat hippocampus. J. Comp. Neurol. 1990;300:433–447
  10. Esclapez M, Houser CR. Somatostatin neurons are a subpopulation of GABA neurons in the rat dentate gyrus: Evidence from colocalization of pre-prosomatostatin and glutamate decarboxylase messenger RNAs. Neuroscience. 1995;64:339–355
  11. Gall C, Lauterborn J, Isackson P, White J. Seizures, neuropeptide regulation, and mRNA expression in the hippocampus. Prog. Brain Res. 1990;83:371–390
  12. Goddard GV, McIntyre DC, Leech CK. A permanent change in brain function resulting from daily electrical stimulation. Expl. Neurol. 1969;25:295–330
  13. Greber S, Schwarzer C, Sperk G. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br. J. Pharmacol. 1994;113:737–740
  14. Gruber B, Greber S, Rupp E, Sperk G. Differential NPY mRNA expression in granule cells and interneurons of the rat dentate gyrus after kainic acid. Hippocampus. 1994;4:1–9
  15. Hashimoto T, Obata K. Induction of somatostatin by kainic acid in pyramidal and granule cells of the rat hippocampus. Neurosci. Lett. 1991;12:514–527
  16. Hökfelt T, Johansson O, Ljungdahl A, Lundberg JM, Schultzberg M. Peptidergic neurones. Nature. 1980;284:515–521
  17. Hökfelt T. Neuropeptides in perspective: The last ten years. Neuron. 1991;7:867–879
  18. Johansen FF, Tonder N, Bruhn T, Diemer NH. Neuropeptide Y immunoreactivity is lost in rat hippocampus after cerebral ischemia and kainic acid seizures. Eur. J. Neurosci. 1989;(Suppl. 2):13
  19. Köhler C, Chan-Palay V. Somatostatin-like immunoreactive neurons in the hippocampus: An immunocytochemical study in the rat. Neurosci. Lett. 1982;34:259–264
  20. Köhler C, Eriksson L, Davies S, Chan-Palay V. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J. Comp. Neurol. 1986;244:384–400
  21. Köhler C, Eriksson LG, Davies S, Chan-Palay V. Co-localization of neuropeptide tyrosine and somatostatin immunoreactivity in neurons of individual subfields of the rat hippocampal region. Neurosci. Lett. 1987;78:1–6
  22. Larhammar D, Ericsson A, Persson H. Structure and expression of the rat neuropeptide Y gene. In: 2nd ed.. Proc. Natl. Acad. Sci. USA. 84:1987;p. 2068–2072
  23. Leranth C, Malcolm AJ, Frotscher M. Afferent and efferent synaptic connections of somatostatin-immunoreactive neurons in the rat fascia dentata. J. Comp. Neurol. 1990;295:111–122
  24. Leung LS. Spontaneous hippocampal interictal spikes following local kindling: Time course of changes and relation to behavioral seizures. Brain Res. 1990;513:308–314
  25. Lothman EW, Bertram EH, Stringer JL. Functional anatomy of hippocampal seizures. Prog. Neurobiol. 1991;37:1–81
  26. Lothman EW, Bertram EH. Epileptogenic effects of status epilepticus. Epilepsia. 1993;34:S59–S70
  27. Manfridi A, Forloni GL, Vezzani A, Fodritto F, De Simoni MG. Functional and histological consequences of quinolinic and kainic acid-induced seizures on hippocampal somatostatin neurons. Neuroscience. 1991;41:127–135
  28. Mazaratti AM, Teledgy G. Effects of somatostatin and anti-somatostatin serum on picrotoxin-kindled seizures. Neuropharmacology. 1992;31:793–797
  29. McNamara JO. Kindling: An animal model of complex partial epilepsy. Ann. Neurol. 1984;16:S72–S76 (Suppl.)
  30. Milner TA, Bacon CE. Ultrastructural localization of somatostatin-like immunoreactivity in the rat dentate gyrus. J. comp. Neurol. 1989;290:544–560
  31. Mitchell J, Gatherer M, Sundstrom LE. Loss of hilar somatostatin neurons following tetanus toxin-induced seizures. Acta Neuropathol. 1995;89:425–430
  32. Monnet FP, Fournier A, Debonnel G, de Montigny C. Neuropeptide Y potentiates response in the CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor. J. Pharmacol. Exp. Ther. 1992;263:1212–1218
  33. Monno A, Rizzi M, Samanin R, Vezzani A. Antisomatostatin antibody enhances the rate of hippocampal kindling in rats. Brain Res. 1993;602:148–152
  34. Peréz J, Vezzani A, Civenni G, Tutka P, Rizzi M, Schupbach E, et al. Functional effects of D-Phe-c-(Cys-Tyr-D-trp-Lys-Val-Cys)-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats. Neuroscience. 1995;65:1087–1097
  35. Pitkanen A, Sirvio J, Jolkkonen J, Riekkinen P. Somatostatin-like immunoreactivity and somatostatin receptor binding in rat brain before and after pentylenetetrazole-induced convulsion. Neuropeptides. 1986;7:63–71
  36. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. clin. Neurophysiol. 1972;32:281–294
  37. Rizzi M, Monno A, Samanin R, Sperk G, Vezzani A. Electrical kindling of the hippocampus is associated with functional activation of neuropeptide Y-containing neurons. Eur. J. Neurosci. 1993;5:1534–1538
  38. Robbins RJ, Brines ML, Kim JH, Adrian T, de-Lanerolle N, Welsh MS, et al. A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy. Ann. Neurol. 1991;29:325–332
  39. Roder, C., Schwarzer, C., Vezzani, A., Gobbi, M., Mennini, T. and Sperk, G., Autoradiographic analysis of neuropeptide Y binding sites in the rat hippocampus after kainic acid-induced limbic seizures, Neuroscience, in press.
  40. Scharfman HE, Schwartzkroin PA. Responses of cells of the rat fascia dentata to prolonged stimulation of the perforant path: Sensitivity of hilar cells and changes in granule cell excitability. Neuroscience. 1990;35:491–504
  41. Scharfman HE. Presynaptic and postsynaptic actions of somatostatin in area CA1 and the dentate gyrus of rat and rabbit hippocampal slices. In:  Dunwiddie TV,  Lovinger DM editor. Presynaptic Receptors in the Mammalian Brain. Boston: Birkhauser; 1993;p. 42–70
  42. Schwarzer C, Williamson JM, Lothman EW, Vezzani A, Sperk G. Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsy. Neuroscience. 1995;69:831–845
  43. Shinoda H, Nadi NS, Schwartz JP. Alterations in somatostatin and proenkephalin mRNA in response to a single amygdaloid stimulation versus kindling. Mol. Brain Res. 1991;11:221–226
  44. Sloviter RS. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy. Science. 1987;235:73–76
  45. Sloviter RS, Nilaver G. Immunocytochemical localization of GABA- cholecystokinin-, vasoactive intestinal polypeptide-, and somatostatin-like immunoreactivity in the area dentata and hippocampus of the rat. J. comp. Neurol. 1987;256:42–60
  46. Sloviter RS, Lowenstein DH. Heat shock protein expression in vulnerable cells of the rat hippocampus as an indicator of excitation-induced neuronal stress. J. Neurosci. 1992;12:3004–3009
  47. Sperk G, Marksteiner J, Gruber B, Bellmann R, Mahata M, Ortler M. Functional changes in neuropeptide Y and somatostatin containing neurons induced by limbic seizures in the rat. Neuroscience. 1992;50:831–846
  48. Sperk G. Kainic acid seizures in the rat. Prog. Neurobiol. 1994;42:1–32
  49. Sternberger L. Immunohistochemistry. 2nd ed.. New York: Wiley; 1979;
  50. Stringer J, Lothman EW. Bilateral maximal dentate activation is critical for the appearance of an after-discharge in the dentate gyrus. Neuroscience. 1992;46:309–314
  51. Tavianini MA, Hayes TE, Magazin MD, Minth CD, Dixon JE. Isolation, characterization, and DNA sequence of the rat somatostatin gene. J. biol. Chem. 1984;259:11798–11803
  52. Vezzani A, Serafini R, Stasi MA, Vigano' G, Rizzi M, Samanin R. Somatostatin and its octapeptide analog SMS 201–995 modulate seizures induced by quinolinic and kainic acids differently in the rat hippocampus. Neuropharmacology. 1991;30:345–352
  53. Vezzani A, Monno A, Rizzi M, Galli A, Barrios M, Samanin R. Somatostatin release is enhanced in the hippocampus of partially and fully kindled rats. Neuroscience. 1992;51:41–46
  54. Vezzani A, Civenni G, Rizzi M, Monno A, Messali S, Samanin R. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 1994;660:138–143
  55. Wanscher B, Kragh J, Barry DI, Bolwig T, Zimmer J. Increased somatostatin and enkephalin-like immunoreactivity in the rat hippocampus following hippocampal kindling. Neurosci. Lett. 1990;118:33–36
  56. Ylinen A, Valjakka A, Lahtinen H, Miettinen R, Freund TF, Riekkinen P. Vigabatrin pre-treatment prevents hilar somatostatin cell loss and the development of interictal spiking activity following sustained stimulation of the perforant path. Neuropeptides. 1991;19:205–211
  57. Young WS. In situ hybridization. Histochemical detection of neuropeptide mRNA using DNA and RNA probes. Methods Enzymol. 1989;168:702–709

PII: S0920-1211(96)00059-9

Epilepsy Research
Volume 26, Issue 1 , Pages 267-279 , December 1996

Article Tools